IndiaTickerLatest filing: Suven Life Sciences Ltd - 530239 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
ObservedCompany dossier
Suven Life Sciences
NSE:SUVEN · ISIN INE495B01038
- Close
- ₹313.35 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Suven Life Sciences
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹1.6 Cr · PAT ₹-39.1 Cr.
Exchange XBRLLatest ownership: promoter group 65.47% and public 34.53% as of 08 Jul 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Suven Life Sciences Ltd - 530239 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
BSE · exchange filing
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Suven Life Sciences Limited
NSE · conference call
Observed
Source filing Copy of Newspaper Publication - Suven Life Sciences Limited
NSE · exchange filing
Observed
Source filing Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹1.6 Cr
- Profit after tax
- ₹-39.1 Cr
- EPS
- ₹-1.79
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →08 Jul 2026
- Promoter group
- 65.47%
- Public
- 34.53%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL